| Cell line name |
MSR3-mel |
|---|
| Synonyms |
AUMA |
|---|
| Accession |
CVCL_VV18 |
|---|
| Resource Identification Initiative |
To cite this cell line use: MSR3-mel (RRID:CVCL_VV18) |
|---|
| Comments |
Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014. |
|---|
| HLA typing |
Source: PubMed=11668505
| Class I | | HLA-A | A*01:01,11:01 | | HLA-B | B*37:01,52:01:01:01 | | HLA-C | C*06:02,12:02 |
|
|---|
| Disease |
Melanoma (NCIt: C3224) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Hierarchy |
Children:
|
|---|
| Originate from same individual |
CVCL_VV17 ! MSR3-EBV |
|---|
| Category |
Cancer cell line |
|---|
| Publications | PubMed=10363990
Tanzarella S., Russo V., Lionello I., Dalerba P., Rigatti D., Bordignon C., Traversari C.
Identification of a promiscuous T-cell epitope encoded by multiple members of the MAGE family.
Cancer Res. 59:2668-2674(1999) PubMed=11668505; DOI=10.1002/ijc.1452
Serrano A., Tanzarella S., Lionello I., Mendez R., Traversari C., Ruiz-Cabello Osuna F., Garrido F.
Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2'-deoxycytidine treatment.
Int. J. Cancer 94:243-251(2001) |
|---|
| Cross-references |
|---|
| Encyclopedic resources |
Wikidata; Q95991314
|
|---|
| Entry history |
|---|
| Entry creation | 24-May-2019 |
|---|
| Last entry update | 29-Jun-2023 |
|---|
| Version number | 4 |
|---|
